Prevention & Chronic Conditions

About

Cardiovascular disease (CVD) is a significant and ever-growing problem in the UK, accounting for nearly one-third of all deaths and leading to significant morbidity. Globally CVD accounts for 31% of mortality, mainly from heart disease and cerebrovascular accident.

The burden of CVD can be ameliorated by careful risk modification and primary prevention is an important priority for all developers of health policy. Strong consensus exists between international guidelines regarding the necessity of smoking cessation, weight optimisation and exercise, although guidelines have slightly different approaches to hypertension and vary considerably regarding their approach to optimal lipid profile, which remains a contentious issue.

Articles

Complications in Anticoagulated Patients with AF

Citation:

Arrhythmia & Electrophysiology Review 2017;6(4):167–78.

Drug–Drug and Drug–Food Interactions of Oral Anticoagulation

Citation:

Arrhythmia & Electrophysiology Review 2018;7(1):55–61.

End-of-life Management of Leadless Cardiac Pacemaker Therapy

Citation:

Arrhythmia & Electrophysiology Review 2017;6(3):129–33

Executive Summary: European Heart Rhythm Association Consensus Document on the Management of Supraventricular Arrhythmias

Citation:

Arrhythmia & Electrophysiology Review 2016;5(3):210–4.